中外健康文摘
中外健康文摘
중외건강문적
WORLD HEALTH DIGEST
2014年
18期
66-66
,共1页
颅内动脉瘤%蛛网膜下腔出血%血管痉挛%效果分析
顱內動脈瘤%蛛網膜下腔齣血%血管痙攣%效果分析
로내동맥류%주망막하강출혈%혈관경련%효과분석
subarachnoid%hemorrhage of intracranial aneurysm%Vasospasm%effect analysis
目的:探讨和分析颅内动脉瘤性蛛网膜下腔出血血管痉挛的临床治疗效果。方法抽取我院2012年1月-2014年1月收治的颅内动脉瘤性蛛网膜下腔出血血管痉挛的患者72例,随机分为对照组和治疗组两组各36例。对照组给与常规治疗,治疗组在常规治疗的基础上给与盐酸川芎嗪注射液联合依达拉奉注射液治疗,对两组的治疗效果进行回顾性分析。结果通过治疗,对照组有效26例(72.2%),死亡10例(27.8%),治疗组有效32例(88.9%),死亡4例(11.1%)。治疗组在有效率、死亡率及并发症等方面都优于对照组,两组差异显著,具有统计学意义。结论盐酸川芎嗪注射液联合依达拉奉注射液治疗颅内动脉瘤性蛛网膜下腔出血血管痉挛效果良好,安全性能高,并发症少,值得临床推广应用。
目的:探討和分析顱內動脈瘤性蛛網膜下腔齣血血管痙攣的臨床治療效果。方法抽取我院2012年1月-2014年1月收治的顱內動脈瘤性蛛網膜下腔齣血血管痙攣的患者72例,隨機分為對照組和治療組兩組各36例。對照組給與常規治療,治療組在常規治療的基礎上給與鹽痠川芎嗪註射液聯閤依達拉奉註射液治療,對兩組的治療效果進行迴顧性分析。結果通過治療,對照組有效26例(72.2%),死亡10例(27.8%),治療組有效32例(88.9%),死亡4例(11.1%)。治療組在有效率、死亡率及併髮癥等方麵都優于對照組,兩組差異顯著,具有統計學意義。結論鹽痠川芎嗪註射液聯閤依達拉奉註射液治療顱內動脈瘤性蛛網膜下腔齣血血管痙攣效果良好,安全性能高,併髮癥少,值得臨床推廣應用。
목적:탐토화분석로내동맥류성주망막하강출혈혈관경련적림상치료효과。방법추취아원2012년1월-2014년1월수치적로내동맥류성주망막하강출혈혈관경련적환자72례,수궤분위대조조화치료조량조각36례。대조조급여상규치료,치료조재상규치료적기출상급여염산천궁진주사액연합의체랍봉주사액치료,대량조적치료효과진행회고성분석。결과통과치료,대조조유효26례(72.2%),사망10례(27.8%),치료조유효32례(88.9%),사망4례(11.1%)。치료조재유효솔、사망솔급병발증등방면도우우대조조,량조차이현저,구유통계학의의。결론염산천궁진주사액연합의체랍봉주사액치료로내동맥류성주망막하강출혈혈관경련효과량호,안전성능고,병발증소,치득림상추엄응용。
objective to investigate and analyze intracranial aneurysmal subarachnoid hemorrhage clinical therapeutic effects of vasospasm.Methods from January 2012 - January 2014 intracranial aneurysmal subarachnoid hemorrhage vasospasm of 72 cases of patients, two groups were randomly divided into control group and treatment group (n = 36).Control group given conventional treatment, the treatment group on the basis of conventional treatment gives the ligustrazine hydrochloride injection adr mentioned joint injection treatment, the treatment effect of two groups were retrospectively analyzed. Results through treatment, the control group 26 cases (72.2%), 10 cases died (27.8%), effective treatment group 32 cases (88.9%), 4 cases died (11.1%).Treatment group in efficient, mortality and complications were superior to that in control group, significant difference, the two groups have statistical significance. Conclusion ligustrazine hydrochloride injection adr mentioned joint injection treatment of intracranial aneurysmal subarachnoid hemorrhage vasospasm has good effectiveness, safety performance is high, fewer complications, worthy of clinical popularization and application.